Historical Stock Price
ETFs Holding SRPT »    SRPT Split History »



Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
02/21/2024 $134.82 $136.25 $130.50 $132.29 806.00K
02/22/2024 $132.28 $136.50 $131.76 $134.78 763.60K
02/23/2024 $136.12 $137.51 $135.14 $136.53 570.70K
02/26/2024 $136.30 $138.97 $135.35 $137.65 630.50K
02/27/2024 $138.73 $142.16 $137.96 $141.53 877.90K
Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping.
SRPT historical stock prices picture
Sarepta Therapeutics (SRPT) has the following price history information. Looking back at SRPT historical stock prices for the last five trading days, on February 21, 2024, SRPT opened at $134.82, traded as high as $136.25 and as low as $130.50, and closed at $132.29. Trading volume was a total of 806.00K shares. On February 22, 2024, SRPT opened at $132.28, traded as high as $136.50 and as low as $131.76, and closed at $134.78. Trading volume was a total of 763.60K shares. On February 23, 2024, SRPT opened at $136.12, traded as high as $137.51 and as low as $135.14, and closed at $136.53. Trading volume was a total of 570.70K shares. On February 26, 2024, SRPT opened at $136.30, traded as high as $138.97 and as low as $135.35, and closed at $137.65. Trading volume was a total of 630.50K shares. On February 27, 2024, SRPT opened at $138.73, traded as high as $142.16 and as low as $137.96, and closed at $141.53. Trading volume was a total of 877.90K shares.

SRPT Historical Stock Prices By Date:

SRPT historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sarepta Therapeutics shares, starting with a $10,000 purchase of SRPT, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/03/2014
End date: 02/27/2024
Start price/share: $28.36
End price/share: $141.53
Dividends collected/share: $0.00
Total return: 399.05%
Average Annual Total Return: 17.45%
Starting investment: $10,000.00
Ending investment: $49,905.39
Years: 9.99
Date Close
02/21/2024$132.29
02/22/2024$134.78
02/23/2024$136.53
02/26/2024$137.65
02/27/2024$141.53
SRPT is categorized under the Healthcare sector; below are some other companies in the same sector:

SRRA Historical Stock Prices
SRTS Historical Stock Prices
SSH Historical Stock Prices
SSKN Historical Stock Prices
SSRG Historical Stock Prices
SSY Historical Stock Prices
STAA Historical Stock Prices
STE Historical Stock Prices
STEM Historical Stock Prices
STJ Historical Stock Prices

Also explore: SRPT shares outstanding history

Email EnvelopeFree SRPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

SRPT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.